» Articles » PMID: 39161095

Respiratory Syncytial Virus: Challenges in Diagnosis and Impact on the Elderly: Recommendations from a Multidisciplinary Panel

Abstract

Respiratory syncytial virus (RSV) is an important cause of respiratory illness. While most attention is paid to childhood infection, the RSV burden in adults ≥60 y should also be considered. In Brazil, this is generally underrecognized, where greater focus is toward other respiratory pathogens. This article presents insights from a multidisciplinary panel gathered to review epidemiologic data and current diagnostic approaches to RSV in Brazil (and their limitations) and develop communication strategies to improve knowledge and awareness. National surveillance data indicate a steady increase in cases of RSV-related severe acute respiratory illness (RSV-SARI) in those aged ≥60 y in recent years, with high fatality rates (>30%). Routine RSV testing in older individuals with respiratory symptoms is relatively low. Educational activities targeted toward health-care professionals and the general public are critical to raising awareness of the importance of RSV in older individuals, particularly as protective vaccines are now available.

Citing Articles

Perceived benefits, information, vaccination history, and conspiracy beliefs as significant determinants of RSV vaccine acceptance among Arab seniors.

Sallam M, Al-Mahzoum K, Yousef Z, Alfouzan J, Alharbi M, Alsubaiei M Ther Adv Vaccines Immunother. 2025; 13:25151355251324384.

PMID: 40027198 PMC: 11869265. DOI: 10.1177/25151355251324384.


Viral sepsis: diagnosis, clinical features, pathogenesis, and clinical considerations.

Xu J, Zhang W, Fu J, Fang X, Gao C, Li C Mil Med Res. 2024; 11(1):78.

PMID: 39676169 PMC: 11648306. DOI: 10.1186/s40779-024-00581-0.

References
1.
Branche A, Saiman L, Walsh E, Falsey A, Jia H, Barrett A . Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults. Influenza Other Respir Viruses. 2022; 16(6):1151-1160. PMC: 9530534. DOI: 10.1111/irv.13043. View

2.
Ramirez J, Carrico R, Wilde A, Junkins A, Furmanek S, Chandler T . Diagnosis of Respiratory Syncytial Virus in Adults Substantially Increases When Adding Sputum, Saliva, and Serology Testing to Nasopharyngeal Swab RT-PCR. Infect Dis Ther. 2023; 12(6):1593-1603. PMC: 10163290. DOI: 10.1007/s40121-023-00805-1. View

3.
Zheng Z, Warren J, Shapiro E, Pitzer V, Weinberger D . Estimated incidence of respiratory hospitalizations attributable to RSV infections across age and socioeconomic groups. Pneumonia (Nathan). 2022; 14(1):6. PMC: 9592130. DOI: 10.1186/s41479-022-00098-x. View

4.
McLaughlin J, Khan F, Begier E, Swerdlow D, Jodar L, Falsey A . Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysis. Open Forum Infect Dis. 2022; 9(7):ofac300. PMC: 9301578. DOI: 10.1093/ofid/ofac300. View

5.
Hurley L, Allison M, Kim L, OLeary S, Crane L, Brtnikova M . Primary care physicians' perspectives on respiratory syncytial virus (RSV) disease in adults and a potential RSV vaccine for adults. Vaccine. 2019; 37(4):565-570. DOI: 10.1016/j.vaccine.2018.12.031. View